SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001395064-24-000100
Filing Date
2024-06-28
Accepted
2024-06-28 08:25:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B2 a424b2-prospectus_062824.htm 424B2 611020
2 EX-FILING FEES exhibit107_062824.htm EX-FILING FEES 29017
3 GRAPHIC logo-1_062824.jpg GRAPHIC 6042
4 GRAPHIC logo-2_062824.jpg GRAPHIC 16255
5 GRAPHIC logo-3_062824.jpg GRAPHIC 9290
  Complete submission text file 0001395064-24-000100.txt   684967
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 424B2 | Act: 33 | File No.: 333-280469 | Film No.: 241081537
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)